Phase II randomized trial of acupuncture-like transcutaneous electrical nerve stimulation to prevent radiation-induced xerostomia in head and neck cancer patients

Journal of the Society for Integrative Oncology

Volumn 8, Issue 2, 2010, Pages 35-42

  Wong, Raimond K ^a   Sagar, Stephen M ^a   Chen, Bao J ^b   Yi, Grace Y ^b   Cook, Richard ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

A cupuncture; Prevention; Radiation therapy; Transcutaneous electrical nerve stimulation; Xerostomia

Indexed keywords

ACUPUNCTURE; ACUPUNCTURE LIKE TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION; ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MOUTH HYGIENE; PHASE 2 CLINICAL TRIAL; RADIATION INDUCED XEROSTOMIA; RANDOMIZED CONTROLLED TRIAL; SALIVA; TRANSCUTANEOUS NERVE STIMULATION; VISUAL ANALOG SCALE; XEROSTOMIA; HEAD AND NECK TUMOR; TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION;

PILOCARPINE;

ACUPUNCTURE THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; PILOCARPINE; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; XEROSTOMIA;

EID: 77950871710     PISSN: 1715894X     EISSN: None     Source Type: Journal    
DOI: 10.2310/7200.2009.0022     Document Type: Article

References (26)

1. Braam PM, Terhaard CHJ, Roesink JM, Raaijmakers CPJ. Intensity-modulated radiotherapy significantly reduces xerostomia compared with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:975-980.
2. Haddad P, Karimi M. A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia. Radiother Oncol 2002;64:29-32. (Pubitemid 35223150)
3. Scarantino C, LeVeque F, Swann RS, et al. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. J Support Oncol 2006;4:252-258. (Pubitemid 43756993)
4. Burlage FR, Roesink JM, Kampinga HH, et al. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study. Int J Radiat Oncol Biol Phys 2008;70:14-22.
5. Warde P, O'Sullivan B, Aslanidis J, et al. A phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2002;54:9-13.
6. Wong RKW, Jones GW, Sagar SM, et al. A phase I-II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:472-480.
7. Blom M, Kopp S, Lundeberg T. Prognostic value of the pilocarpine test to identify patients who may obtain long-term relief from xerostomia by acupuncture treatment. Arch Otolaryngol Head Neck Surg 1999;125:561-566. (Pubitemid 29220578)
8. Deng G, Hou BL, Holodny AI, Cassileth BR. Functional magnetic resonance imaging (fMRI) changes and saliva production associated with acupuncture at LI-2 acupuncture point: a randomized controlled study. BMC Complement Altern Med 2008;8:37.
9. Dawidson I, Angmar-Mansson B, Blom M, et al. Sensory stimulation (acupuncture) increases the release of calcitonin gene-related peptide in the saliva of xerostomia sufferers. Neuropeptides 1999;33:244-250. (Pubitemid 29398147)
10. Dawidson I, Angmar-Mansson B, Blom M, et al. Sensory stimulation (acupuncture) increases the release of vasoactive intestinal polypeptide in the saliva of xerostomia sufferers. Neuropeptides 1998;32:543-548. (Pubitemid 29010711)
11. Pomeranz B, Niznik G. Codetron, a new electrotherapy device overcomes the habituation problems of conventional TENS devices. Am J Electomed 1987;2:22-26.
12. World Health Organization, Regional Office for the Western Pacific. Standard acupuncture nomenclature: a brief explanation of 361 classical acupuncture point names and their multilingual comparative list. Manila: World Health Organization, Regional Office for the Western Pacific;1993.
13. Eriksson M, Sjolund B. Acupunture-like electoanalgesia in TNS resistant chronic pain. In: Zotterman Y, editor. Sensory functions of the skin. Oxford: Pergamon Press; 1976. p. 575-581.
14. Ringash J, Warde P, Lockwood G, et al. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys 2005;61:1403-1407. (Pubitemid 40470421)
15. Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993;329:390-395. (Pubitemid 23219343)
16. LeVeque FG, Montgomery M, Potter D, et al. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. J Clin Oncol 1993;11:1124-1131. (Pubitemid 23163354)
17. Mulligan R, Navazesh M, Wood GJ. A pilot study comparing three salivary collection methods in an adult population with salivary gland hypofunction. Spec Care Dentist 1995;15:154-157.
18. Fitzmaurice G, Laird N, Ware J. Applied longitudinal analysis. New York: Wiley; 2004.
19. Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 1994;28:847-856. (Pubitemid 24099866)
20. De A Fernando F, Puri DR, Zhung J, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2006;64:363-373. (Pubitemid 43083420)
21. Seung S, Bae J, Solhjem M, et al. Intensity-modulated radiotherapy for head-and-neck cancer in the community setting. Int J Radiat Oncol Biol Phys. 2008;72:1075-1081.
22. Konings AWT, Coppes RP, Vissink A. On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys 2005;62:1187-1194.
23. Nagler R, Barness-Hadar L, Lieba M, Nagler A. Salivary antioxidant capacity in graft versus host disease. Cancer Invest 2006;24:269-277.
24. Kagami H, Hiramatsu Y, Hishida S, et al. Salivary growth factors in health and disease. Adv Dent Res 2000;14:99-102.
25. Ihrler S, Blasenbreu-Vogt S, Sendelhofert A, et al. Regeneration in chronic sialadenitis: an analysis of proliferation and apoptosis based on double immunohistochemical labelling. Virchows Arch 2004;444:356-361. (Pubitemid 38553641)
26. Jabbari S, Kim HM, Feng M, et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys 2005;63:725-731. (Pubitemid 41400058)